AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
Healthcare
A Look at Imugene’s robust pipeline of B-Cell Vaccines for Cancer Immunotherapy
June 28, 2019 04:36 PM AEST| By Team Kalkine MediaAn Australian-headquartered clinical stage immuno-oncology company, Imugene Limited (ASX: IMU) has a robust pipeline of B cell vaccines aimed at treating a variety of cancers. The company?s pipeline includes multiple product candidates that are used...
AFP’s FY19 Performance - What investors need to know?
May 23, 2019 01:50 PM AEST| By Team Kalkine MediaAFT Pharmaceuticals Limited (ASX: AFP) is a growing pharma company with its head office based out of New Zealand. It officially was listed on ASX in December 2015. On 22nd May 2019, the company published its Investor Presentation and Annual Report, c...
Kazia Therapeutics collaborates with Alliance to investigate new drug, GDC-0084
May 21, 2019 01:42 PM AEST| By Team Kalkine MediaKazia Therapeutics Limited (ASX: KZA) caters to the health care sector and is based out of Sydney, Australia. It is a bio-tech company which focusses on innovative oncology. The company aims to bring out diversified portfolio of new cancer therapies....
GMV executes two Provider Participation Agreements with United States-based companies
May 16, 2019 04:09 PM AEST| By Team Kalkine MediaG Medical Innovations Holdings Limited (ASX: GMV) is a healthcare company focused on digital health solutions. On 16 May 2019, GMV reported that its wholly owned subsidiary G Medical Diagnostic Services Inc (GMEDx) had executed two Provider Particip...
Looking Through The Business Model Of This Drug Development Company – Noxopharm
May 10, 2019 12:06 PM AEST| By Team Kalkine MediaNoxopharm Limited (ASX: NOX) rides on its overarching objective for a treatment ?to harness the body?s immune system to attack all the cancer cells in the body, but with noticeably reduced side-effects. The company is positioned as a clinical-stage d...
Respiri to Enter Indian Market; Announces JV with MedAchievers Private Limited
May 03, 2019 04:17 PM AEST| By Team Kalkine MediaToday, on 3rd May 2019, Respiri Limited (ASX: RSH) announces a Joint Venture Agreement for the company?s entry into India with MedAchievers Private Limited, which is an integrated platform for global healthcare, led by Dr Harsha Vardhan, Founder and...
HeraMED Seeks Approval for HeraBEAT- Submitted 510K Application To FDA
April 29, 2019 06:02 PM AEST| By Team Kalkine MediaHeraMED Limited (ASX: HMD) is a medical technology company. The company offers smart pregnancy monitoring solutions for professional and home use. HeraMED provides peace of mind to expecting parents by solving problems associated with the reliability...
HeraMed collaborates with Meerkats for Australian B2C launch
April 16, 2019 05:18 PM AEST| By Team Kalkine MediaHeraMed Limited (ASX: HMD) is a medical technology company that develops and sells pregnancy monitoring solutions in Australia, Europe, and Israel. On April 16th, 2019, the company announced to have entered into a partnership with Australian creative...
CardieX Limited Provides Interim Corporate Update
April 01, 2019 06:00 PM AEDT| By Team Kalkine MediaOn 1 April 2019, CardieX Limited (ASX: CDX), a company from the healthcare sector engaged into the development and marketing of the SphygmoCor device has reported various corporate activities for its business and its operating subsidiaries for the ca...
Alcidion Group Announces ~$2.1 Mn Deal With Dartford And Gravesham NHS Trust
March 18, 2019 05:16 PM AEDT| By Team Kalkine MediaAlcidion Group Limited (ASX: ALC) announced a strategic partnership worth ~$2.1 Mn with Dartford and Gravesham NHS trust in the UK, over a period of 5 years. The trust will be Alcidion?s first customer outside Australia to adopt its complete product...
Australian Pharmaceutical Releases Market Update on API-Sigma Merger Proposal
March 14, 2019 07:37 PM AEDT| By Team Kalkine MediaAustralian Pharmaceutical Industries Limited (ASX: API) has acknowledged the announcement made by Sigma Healthcare rejecting merger proposal on a non-binding indicative offer made by API. The offer was valued at a premium of 41.8% over the undisturbe...
Opthea Limited Announces the Addition of OPT ticker in All Ordinaries, Effective from March 18, 2019
March 12, 2019 02:59 PM AEDT| By Team Kalkine MediaOpthea Limited (ASX: OPT) is into biotechnology. The company is into the development of a novel biologic therapy, OPT-302, which is used for the treatment of eye diseases, by blocking two members of the vascular endothelial growth factor family VEGF-...
Zoono Group Announces Proceedings Against Stayzon
March 08, 2019 03:51 PM AEDT| By Team Kalkine MediaZoono Group Limited (ASX: ZNO) announced that Stayzon Retail Ventures Pty Limited has been placed into Voluntary Liquidation by its Directors, Shaun David Bell, and Christopher Plastow. As previously stated, Zoono instigated legal action against Sta...
Cardiex announced the extension of Atcor Medical’s pharma contract with Bayer Ag
March 07, 2019 02:38 PM AEDT| By Team Kalkine MediaCardiex Limited (ASX: CDX), a healthcare company engaged into the development and marketing of the SphygmoCor device used for cardiovascular patient assessment and management, announced the extension and expansion of a previous contract awarded to it...
A Shot In The Arm For MGC Pharma, Independent Laboratory Test Validates Proprietary Genetic Strains!
February 26, 2019 03:03 PM AEDT| By Team Kalkine MediaEU based MGC Pharmaceuticals Ltd (ASX: MXC) has received independent verification of its premium grade THC and CBD genetic strains, and with that, the strains are now registered with the EU. Slovenia based University of Ljubljana Biotechnical Faculty...
Auscann Appointed Mr Ido Kanyon As Its CEO – Stock Zoomed Up By 2.353%
February 26, 2019 02:54 PM AEDT| By Team Kalkine MediaAusCann Group Holdings Ltd (ASX: AC8), a company from the health care sector engaged into cultivation, manufacture and supply of medical cannabis products, has announced the appointment of global pharmaceutical business executive, Mr Ido Kanyon as a...
Blackmores’ Shares Tumbled on ASX after Announcing the Resignation of its CEO
February 26, 2019 10:58 AM AEDT| By Team Kalkine MediaAustralia?s leading natural health company, Blackmores Limited (ASX: BKL) has announced the resignation of its Chief Executive Officer (CEO), Mr. Richard Henfrey. Following this news, the share price of the company decreased by 3.918% as on 26 Februa...
COH’s Shares Slipped Around 7.8% on ASX Post Release of 1HFY19 Results
February 19, 2019 03:22 PM AEDT| By Team Kalkine MediaCochlear Limited (ASX: COH) researches develop and market cochlear implant systems for hearing impaired individuals. The Company's hearing implant systems include Nucleus and Baha and are sold both domestically and internationally. On 19 February 20...
Elixinol Global confirms AUD 2.6-million land purchase for subsidiary Nunyara
February 07, 2019 04:52 PM AEDT| By Team Kalkine MediaThe Sydney, Australia-based Elixinol Global Limited (ASX: EXL) has a global business presence in the cannabis industry. The company is engaged in the manufacturing and distribution of industrial hemp-based dietary supplements and foods, skincare prod...
The Share Price Of RHT Zoomed Up By 10% After The Execution Of The Distribution Agreement
January 15, 2019 11:15 PM AEDT| By Team Kalkine MediaResonance Health Limited (ASX: RHT), a medical device software company from the health care equipment & services sector announced that it entered into a distribution agreement with EnvoyAI Inc, a US Delaware Corporation for the distribution of RH...
Advertise your brand on Kalkine Media